| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |